Indication
Gastroesophageal reflux
3 clinical trials
6 products
Clinical trial
A Randomized, Open-label, 2x2 Crossover-design Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics After Oral Administration of AD-212-A or AD-2121 in Healthy Adult VolunteersStatus: Recruiting, Estimated PCD: 2024-06-15
Product
LansoprazoleClinical trial
Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features in a Primary Care Setting: A Pragmatic, Randomized, Single Blind StudyStatus: Terminated, Estimated PCD: 2020-03-30
Product
VonoprazanProduct
OmeprazoleClinical trial
The Role of an EsoDuo® to Control Reflux Symptoms Related to the Acid; a Multicenter, Open-labeled, Phase 4 Study [RACER Study]Status: Recruiting, Estimated PCD: 2025-01-01
Product
EsoDuo